This inventor holds 1 USPTO granted patent. Top assignee: Rappta Therapeutics Oy. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Laura Fourmois: Inventor in Biomedical Research.
Introduction
Laura Fourmois is an inventor based in Montigny-le-Bretonneux, France. Her patent work concerns chemical modulators of protein phosphatase 2A (PP2A), a research area with potential applications in treating a range of diseases.
Latest Patents
Fourmois is associated with 1 patent: “Substituted Cyclic Modulators of Protein Phosphatase 2A (PP2A) and Methods Using Same.” The disclosure describes compounds that modulate PP2A and may be useful in treating, preventing, or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft-versus-host disease, chronic obstructive pulmonary disease, non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
Career Highlights
Fourmois is associated with Rappta Therapeutics Oy. Her patent reflects work on potential therapeutic compounds and methods involving PP2A modulation.
Collaborations
Her listed coworkers include George L. Trainor and Maria Obdulia Rabal Gracia.
Conclusion
Laura Fourmois’s patent work at Rappta Therapeutics Oy focuses on PP2A-modulating compounds with potential relevance to several areas of disease research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile